These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 20386523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.
    Vrbic S, Pejcic I, Vrbic M, Filipovic S.
    J BUON; 2009; 14(1):41-4. PubMed ID: 19373945
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH.
    Cancer; 2001 Jun 15; 91(12):2335-42. PubMed ID: 11413523
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report.
    Tanaka K, Sugitani I, Fujimoto Y.
    Jpn J Clin Oncol; 2011 Sep 15; 41(9):1074-8. PubMed ID: 21791572
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
    Heron DE, Karimpour S, Grigsby PW.
    Am J Clin Oncol; 2002 Oct 15; 25(5):442-6. PubMed ID: 12393980
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
    Asakawa H, Kobayashi T, Komoike Y, Maruyama H, Nakano Y, Tamaki Y, Matsuzawa Y, Monden M.
    Anticancer Res; 1997 Oct 15; 17(4A):2757-62. PubMed ID: 9252711
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
    Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A.
    Cancer; 2005 Apr 01; 103(7):1330-5. PubMed ID: 15739211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment and prognosis of anaplastic thyroid carcinoma].
    Sun CZ, Chen FJ, Zeng ZY, Chen YF, Li QL, Guan Z, Tian SZ.
    Zhonghua Wai Ke Za Zhi; 2006 Nov 01; 44(21):1493-7. PubMed ID: 17349179
    [Abstract] [Full Text] [Related]

  • 19. Adrenocortical carcinoma. Our experience.
    Favia G, Lumachi F, Carraro P, D'Amico DF.
    Minerva Endocrinol; 1995 Mar 01; 20(1):95-9. PubMed ID: 7651289
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.